PrimeRFP SCOUT · Federal Contract Recompete Brief

36C24226N0564Lenalidomide — Exelan Pharmaceuticals Inc

Exelan Pharmaceuticals Inc holds $184.3M across 125 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent 36F79720D0227. The prior award was single-bid — competitive dynamics may favor a challenge. Recompete timing centers on the May 31, 2029 PoP end — agencies typically plan 12–18 months ahead.

242-Network Contract Office 02 (36C242)

Awarding office

Exelan Pharmaceuticals Inc

Recipient

May 31, 2029

PoP end

$5.5M

Obligated

$16.5M

Potential

325412

NAICS

6505

PSC

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Exelan Pharmaceuticals Inc — $90

Contract facts

Federal

Contract number36C24226N0564

Also listed as36C242-26-N-0564

Also listed as36F79720D0227-36C24226N0564

Agency242-Network Contract Office 02 (36C242)

Awarding office242-Network Contract Office 02 (36C242)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentExelan Pharmaceuticals Inc

CAGE6GFC4

UEIFYZXNHSQTMG8

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDV36F79720D0227

Place of performanceBOCA RATON FL

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startJun 1, 2026

PoP end (current)May 31, 2029

Obligated$5.5M

Current value$5.5M

Potential value$16.5M

LENALIDOMIDE is a federal award for 242-Network Contract Office 02 (36C242) held by Exelan Pharmaceuticals Inc. Estimated value $16.5M ($5.5M obligated). Current period of performance ends May 31, 2029. Last award drew 1 bidder. Place of performance: BOCA RATON FL.

Recompete timing

Public

● Expiring in 997 days

Current PoP ends May 31, 2029 (997 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Dec 1, 2027.

Incumbent footprint

Public record

Exelan Pharmaceuticals Inc — $184.3M obligated across 125 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($184.3M) · all agencies

Department of Veterans Affairs (VA)$110.2M · 60%Department of Health and Human Services (HHS)$74.1M · 40%Department of Justice (DOJ)$39K · 0%

Open full company profile →

Related awards

Same parent · incumbent

36C24826N0088

LENALIDOMIDE

$3.8M

Sep 30, 2026

36C26326F0016

LENOLIDOMIDE CAPSULES

$3.6M

Sep 30, 2026

36C26126N0175

VA PALO ALTO LENALIDOMIDE ORAL CAPSULES

$3.0M

Sep 30, 2026

36C26026F0069

PHARM - LENALIDOMIDE

$1.3M

Sep 30, 2026

36C26326F0019

LENALIDOMIDE CAPSULES

$1.2M

Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C24226N0564?

36C24226N0564 (Lenalidomide) is a 242-Network Contract Office 02 (36C242) award with a potential value of $16.5M, currently held by Exelan Pharmaceuticals Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C242-26-N-0564?

36C242-26-N-0564 is the dashed form of PIID 36C24226N0564 (Lenalidomide), held by Exelan Pharmaceuticals Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C24226N0564?

242-Network Contract Office 02 (36C242) awarded 36C24226N0564 to Exelan Pharmaceuticals Inc (potential $16.5M).

Who is the incumbent on 36C24226N0564?

Exelan Pharmaceuticals Inc is the incumbent with $184.3M across 125 related awards in SCOUT’s public footprint. The current period of performance ends May 31, 2029.

When does Exelan Pharmaceuticals Inc’s 36C24226N0564 come up for recompete?

SCOUT tracks a period-of-performance end of May 31, 2029. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 36C24226N0564 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action May 29, 2026